B+
Bull case
20%
Probability
Target price
$6.00
+66.7% vs current
ORMP
OramedFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
55%
Probability
Target price
$3.30
-8.3% vs current
B-
Bear case
25%
Probability
Target price
$1.80
-50.0% vs current
AI sentiment snapshot
Latest data as of 2026-01-09
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+45.0
Score
AI commentary
Market consensus price targets are narrowly clustered slightly below the anchor, producing a cautious/neutral tone among analysts [#SERP-1][#SERP-2]. Retail and forum discussion is mixed, with attention focused on upcoming corporate updates and the platform's ability to attract partners [#SERP-7]. The bull view requires binary positive clinical/BD outcomes within the next year to justify material upside; absent those outcomes, the consensus targets act as a near-term reference point.
RankAlpha Sentiment AI - 2026-01-09
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-09catalystNext quarterly/earnings updateHigh impact
Regular quarterly financial update / corporate progress (no firm date disclosed). Market typically re-prices on revenue guidance, cash/burn commentary and program milestones; consensus price targets cluster near $3.25–3.32 which may compress upside [#SERP-1][#SERP-2].
2026-06-30eventPartnership or licensing announcement (business development)High impact
A strategic licensing or commercial partnership would materially de-risk commercialization and could re-rate the equity; no public window disclosed, assumption: near-term BD activity may conclude in H1 2026 (using end of window) [#SERP-2].
2027-01-09catalystClinical program readouts / regulatory progressHigh impact
Potential trial readouts or regulatory interactions on oral protein delivery programs remain the principal long-term value drivers; timing is uncertain and could be >12 months [#SERP-7].
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-09 • Updated nightlySource: Internal modelMethodology